calendar

2 catalysts · 128 approval · 2 phase readout · 1 phase 1 initiation · 1 phase 2 completion

★ save view ↓export CSV

next 91 dayslessmore

MonWedFri

view

agenda month

hide past →

sort

soonest latest type sponsor alpha

matching 'Keytruda'×type: phase readout×clear all

type

approval128
phase readout2
phase 1 initiation1
phase 2 completion1

therapy area

no tagged catalysts yet

Date TBD

›

RECRUITING

phase readout

NCT07180862: A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

Sponsor: Bio-Thera Solutions. Phase: PHASE1. Conditions: Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗

›COMPLETEDphase readoutNCT06307093: Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms

Sponsor: R-Pharm. Phase: PHASE1. Conditions: Skin Melanoma, Squamous Non-small-cell Lung Cancer, Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗